USA Intrauterine Contraceptive Devices (IUD) Market: By Method (Hormonal Intrauterine Devices and Copper Intrauterine Devices), By End-User (Hospitals, Gynecology Clinics, Community Health Care Centers, and Others), and Geography

Purchase Option

$ 3100
$ 4600
$ 6900

USA Intrauterine Contraceptive Devices (IUD) Market size was valued at USD 1,072.3 million in 2023 and is expected to grow at a CAGR of 4.0% from 2024 to 2030. USA intrauterine Contraceptive Devices (IUD). According to the World Health Organization (WHO), an intrauterine device (IUD) is a long-term contraception method. IUDs are small devices that are placed inside the uterus (womb) to prevent pregnancy. IUDs are more potential and reliable, lasting for more than 5 years. The vital factors for the growth of the intrauterine contraceptive devices (IUD) market include technology advancements resulting in effective contraception and a subordinate number of side effects, the rising rate of unintended pregnancies, and favorable government initiatives and private firms for the prohibition of unwanted abortions and pregnancies. An unintended pregnancy is an unsolicited pregnancy. Not utilizing contraceptives or inappropriate use of contraceptive methods can result in unintended pregnancies.

The probability of unintended is mores in juveniles younger than 18 years and, later on, women in the age group of 21 to 25 years. these unintended pregnancies are directly contributing to the increased demand for intrauterine contraceptive devices. Furthermore, the number of unsolicited pregnancies is rising, and this has become of serious concern. For instance, according to the World Health Organization (WHO), unintended pregnancies have been a crucial public health issue. about 24 million unsafe abortions were evaluated to take place each year, which resulted in the death of an evaluated 52,000 women, as per the International Federation of Medical Students' Associations 2018 review. However, the high cost of treatment, the stringent regulatory framework for product approval, and high R&D expenditure remain substantial barriers that hamper the growth of the USA intrauterine Contraceptive Devices (IUD) market However, the key opportunities associated with these drugs are enhanced affordability and patient access to these critical treatments, geographical expansion by the market players, and government incentives for R&D activities create opportunity for the players in the USA intrauterine Contraceptive Devices (IUD) market.

USA Intrauterine Contraceptive Devices (IUD) Market Key Developments:

In June 2021, Sebela Pharmaceuticals Inc., in association with PRA Health Sciences is regulating a phase III clinical trial to evaluate LevoCept, a long-acting reversible intrauterine system for contraceptive tolerability, safety, and efficacy.

USA intrauterine Contraceptive Devices (IUD) Market Dynamics

The increasing prevalence of unintended pregnancies across the country is the major factor driving the USA intrauterine Contraceptive Devices (IUD) market and is expected to grow significantly over the forecast years. The US Government has instigated several launches aimed at increasing awareness about reproductive and sexual health, particularly among the teenagers and fille, as well as providing grants to help avoid unintended pregnancies. For instance, the Office of Population Affairs' Teen Pregnancy Prevention (TPP) Program funds a variety of groups across the United States that attempt to prevent teen pregnancy. Sequentially these proactive measures are anticipated to bolster the Long-acting reversible contraceptives (LARC) utilization among the women consequently boosting the US intrauterine contraceptive devices market development. Currently, In the United States, the VeraCept Intrauterine Contraceptive is now being tested in a clinical trial. (Its use is restricted to investigational purposes under US federal law). VeraCept is a low-dose copper-releasing intrauterine device that prevents pregnancy without the need for hormones. In the United States, VeraCept is conducting Phase 3 Clinical Trials. Moreover, rise in the R&D activities for the launch of novel treatments and novel devices also burgeoned the growth of USA intrauterine contraceptive devices (IUD) market in the forecast period.

USA Intrauterine Contraceptive Devices Market Segmentation

By Method
  • Hormonal Intrauterine Devices
  • Copper Intrauterine Devices
By End User
  • Hospitals
  • Gynecology Clinics
  • Community Health Care Centers
  • Others

Frequently Asked Questions

The USA intrauterine contraceptive devices (IUD) market size is expanded to be valued at USD 1,072 Million and is anticipated to grow at a CAGR of 4.0% over the forecast period.

AbbVie, Bayer AG, Copper companies, Viatris Inc., Sebla Pharmaceticals, Cooper Surgical Inc., DKT International, EUROGINE, S.L, Gima Spa, HLL LifecareLTd., Krishco Medical Products Pvt, Ltd., Laborator HRA Pharma SAS, Melbea Innovations Ltd., Meril Life sciences Pvt.Ltd., Ocon Medical Ltd., Pregna International Ltd, Prosan International BV, SMB Corp. of India, TESPRO LLC, TRIMEDIC SUPPLY NETWORK Ltd., and Viatris.

Historic years considered for the market study are 2019 through 2023, 2023 is considered as the base year for market estimation and ten years forecast presented from 2024– 2030.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023) and forecast (2024-2030)
  • The report covers the in-detail insights into the competitor’s overview, company share analysis, key market developments and their key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report track recent innovations, key developments and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario.
  • AbbVie
  • Bayer AG
  • Copper companies
  • Viatris Inc.,
  • Sebla Pharmaceticals
  • Cooper Surgical Inc.
  • DKT International
  • EUROGINE, S.L
  • Gima Spa
  • HLL LifecareLTd.
  • Krishco Medical Products Pvt, Ltd.
  • Laborator HRA Pharma SAS
  • Melbea Innovations Ltd.
  • Meril Life sciences Pvt.Ltd.
  • Ocon Medical Ltd.
  • Pregna International Ltd
  • Prosan International BV
  • SMB Corp. of India
  • TESPRO LLC
  • TRIMEDIC SUPPLY NETWORK Ltd.

Adjacent Markets